Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects

Clinical trial NCT00694993 · COMPLETED

Trial details

NCT number: NCT00694993
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rhinitis, Allergic, Seasonal

Start date: 2007-12-17
Primary completion: 2008-05-26
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.